MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-UP-01-0003417
Styron Pharmaceuticals Private Limited
Styron Pharmaceuticals Private Limited - chemicals in Agra, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹31.32 Lakh
▲ 52% YoY
Net profit · FY 2025
₹1,654
Net margin 0.1%
EBITDA · FY 2025
₹1,654
EBITDA margin 0.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Styron Pharmaceuticals Private Limited
Data last updated:
Styron Pharmaceuticals Private Limited is a private limited company based in Agra, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 18 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24231UP2020PTC132850. Its GSTIN is 09ABECS2105G1ZM (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rishabh Sharma and Anshul Singh.
Its last annual general meeting (AGM) was held on 20 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No.21 Sushil Nagar Naraich, Agra, Uttar Pradesh, India – 282001.
As per the financials filed for FY 2025, the company reported a revenue of ₹31.32 Lakh, a growth of 52% compared to the previous year. For the same year it recorded a net profit of ₹1,654 (net margin 0.1%) and EBITDA of ₹1,654 (EBITDA margin 0.1%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years.
Styron Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-01-0003417).
Company details
CIN U24231UP2020PTC132850
Registration Number 132850
Incorporation Date 18 August 2020
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 20 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-UP-01-0003417
Key People
Rishabh Sharma Director Anshul Singh Director Recognitions & Rankings of Styron Pharmaceuticals
Contact details
Styron Pharmaceuticals Private Limited's registered office is in Agra, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressHouse No.21 Sushil Nagar Naraich, Agra, Uttar Pradesh, India – 282001
- IndustryChemicals, Manufacturing, Pharmaceutical Chemical, Other Chemical Product
To see the full contact details of Styron Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Styron Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Styron Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Styron Pharmaceuticals Private Limited, buy the company report.
Financials of Styron Pharmaceuticals Private Limited
FY 2025 filings availableStyron Pharmaceuticals Private Limited reported revenue of ₹31.32 Lakh (up 52% YoY) for FY 2025.
Revenue · FY 2025
₹31.32 Lakh ▲ 52%
Net profit · FY 2025
₹1,654 margin 0.1%
EBITDA · FY 2025
₹1,654 margin 0.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 52%
3 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▲ 148%
3 years · compounded
▼ 60%
Revenue has grown at a compounded annual rate (CAGR) of 20% over three years, including 52% growth in the latest year. EBITDA rose 148% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1,654 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,654 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.1% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Styron Pharmaceuticals Private Limited, buy the company report.
Board of directors of Styron Pharmaceuticals Private Limited
Styron Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rishabh Sharma | Director | 18 Aug 2020 | 6 Years 2 Months | Current |
| Anshul Singh | Director | 18 Aug 2020 | 6 Years 2 Months | Current |
Peer comparison
Styron Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bemaxx Pharmaceuticals Private Limited | ₹31.34 Lakh (FY 2024) | 12.0% | Chennai, Tamil Nadu, India | |||
| Cathartic Pharmaceuticals Private Limited | ₹31.33 Lakh (FY 2024) | 77.0% | Panchkula, Haryana, India | |||
| Styron Pharmaceuticals Private Limitedthis company | ₹31.32 Lakh (FY 2025) | ₹1,654 | 0.1% | 52.0% | Agra, Uttar Pradesh, India | |
| Nuera Pharmaceuticals Private Limited | ₹31.23 Lakh (FY 2025) | 73.0% | Bhopal, Madhya Pradesh, India | |||
| Biotical Pharmaceuticals Private Limited | ₹31.18 Lakh (FY 2025) | -54.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Styron Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Styron Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Styron Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Styron Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 04, 2024.
Active EPFO establishments
1
GST
Styron Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09ABECS2105G1ZM | Uttar Pradesh | Active | 14 Sep 2020 |
To see the full GST registrations and return filing status of Styron Pharmaceuticals Private Limited, buy the company report.
Recent activity
Styron Pharmaceuticals Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Shivji Rawat ceased to be Director on 26 Aug 2021.
AGM
Styron Pharmaceuticals Private Limited last Annual general meeting of members was held on 20 Sep 2025 as per latest MCA records.
Filing
Styron Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh Ii.
Ceased
Shivji Rawat ceased to be Director.
Appointed
Anshul Singh was appointed as Director.
Appointed
Rishabh Sharma was appointed as Director.
Incorporation
18 Aug 2020
Styron Pharmaceuticals Private Limited was registered on 18 Aug 2020 with Roc Uttar Pradesh Ii & aged 6 years 2 months as per MCA records.
Frequently asked questions
Styron Pharmaceuticals is an active private limited company based in Agra, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 18 August 2020 (6+ years old) and is registered under CIN U24231UP2020PTC132850.
Styron Pharmaceuticals has 2 current directors:
- Rishabh Sharma - Director
- Anshul Singh - Director
The latest financial statements of Styron Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 20 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Styron Pharmaceuticals is 09ABECS2105G1ZM, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Styron Pharmaceuticals is U24231UP2020PTC132850. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Styron Pharmaceuticals was incorporated on 18 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Styron Pharmaceuticals by revenue are Bemaxx Pharmaceuticals Private Limited, Cathartic Pharmaceuticals Private Limited, Nuera Pharmaceuticals Private Limited, Biotical Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Shivji Rawat ceased to be Director on 26 Aug 2021. Anshul Singh was appointed as Director on 18 Aug 2020. Rishabh Sharma was appointed as Director on 18 Aug 2020.
Yes, Styron Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-01-0003417).
The registered office of Styron Pharmaceuticals is at House No.21 Sushil Nagar Naraich, Agra, Uttar Pradesh, India – 282001.
Styron Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.